Results 161 to 170 of about 24,420 (229)

Central AT1 receptor signaling by circulating angiotensin II is permissive to acute intermittent hypoxia-induced sympathetic neuroplasticity.

J Appl Physiol (1985), 2020
Shimoura CG, Andrade MA, Toney GM.
europepmc   +1 more source

Tissue Transglutaminase-Mediated AT1 Receptor Sensitization Underlies Pro-inflammatory Cytokine LIGHT-Induced Hypertension. [PDF]

Am J Hypertens, 2019
Liu C, Luo R, Wang W, Peng Z, Johnson GVW, Kellems RE, Xia Y.   +6 more
europepmc   +1 more source

Review: AT1-receptors in the central nervous system

Journal of the Renin-Angiotensin-Aldosterone System, 2001
Andrew M, Allen, Michelle E, Giles, JooHyung, Lee, Brian J, Oldfield, Frederick Ao, Mendelsohn, Michael J, McKinley   +5 more
openaire   +2 more sources

The angiotensin II/AT1 receptor pathway mediates malaria-induced acute kidney injury. [PDF]

PLoS One, 2018
Silva LS, Peruchetti DB, Silva-Aguiar RP, Abreu TP, Dal-Cheri BKA, Takiya CM, Souza MC, Henriques MG, Pinheiro AAS, Caruso-Neves C.   +9 more
europepmc   +1 more source

Angiotensin AT₁ receptor antagonism by losartan stimulates adipocyte browning via induction of apelin. [PDF]

J Biol Chem, 2020
Kim DY, Choi MJ, Ko TK, Lee NH, Kim OH, Cheon HG.   +5 more
europepmc   +1 more source

Effects of cholesterol on the GPCR AT1 receptor and its interplay with AT1 antagonists

, 2022
Kiriakidi, S., Cournia, Z., Mavromoustakos, T.   +2 more
openaire   +3 more sources

The AT1 Receptor Antagonist Losartan Does Not Affect Depressive-Like State and Memory Impairment Evoked by Chronic Stressors in Rats. [PDF]

Front Pharmacol, 2019
Costa-Ferreira W, Morais-Silva G, Gomes-de-Souza L, Marin MT, Crestani CC.   +4 more
europepmc   +1 more source

ACE inhibitors, AT1 receptor blockers and COVID-19: clinical epidemiology evidences for a continuation of treatments. The ACER-COVID study

, 2020
Dauchet L, Lambert M, Gauthier V, Poissy J, Faure K, Facon A, Yelnik C, Panaget S, Plagnieux T, Verfaillie F, Mathieu D, Goldstein P, Meirhaeghe A, Amouyel P.   +13 more
europepmc   +1 more source

Beneficial Effects of Combined AT1 Receptor/Neprilysin Inhibition (ARNI) Versus AT1 Receptor Blockade Alone in the Diabetic Eye. [PDF]

Invest Ophthalmol Vis Sci, 2016
Prasad T, Roksnoer LC, Zhu P, Verma A, Li Y, Batenburg WW, de Vries R, Danser AH, Li Q.   +8 more
europepmc   +1 more source